Stable pharmaceutical composition and methods of using same

CAFC
  • US 8,501,225 B2
  • Filed: 09/13/2012
  • Issued: 08/06/2013
  • Est. Priority Date: 04/29/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a subject with fasting triglycerides of at least 500 mg/dl comprising, orally administering to the subject daily for a period of 12 weeks a pharmaceutical composition comprising about 2500 mg to 5000 mg of ethyl eicosapentaenoate present in one or more capsules, effective to lower triglycerides in the subject by at least 25% without increasing LDL-C by more than 5%.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×